Chimera

The only confirmed parent for Chimera is White Truffle, and that genetic tie helps explain why Chimera presents as a rounded hybrid rather than an extreme sativa or indica. Parentage often transfers cannabinoid ratios, aroma compounds and growth tendencies to offspring; while we don’t have specific lab terpene data here, White Truffle’s presence in the pedigree suggests Chimera draws structural and chemical cues from that lineage, which can result in a nuanced, layered profile.

At 25% THC Chimera measures above the catalog average (~20% THC) - roughly a 25% increase over the typical level. In practical terms that usually translates to a stronger effect at similar consumption amounts, so modest dosing is wise for those new to potent hybrids. Because terpenes interact with cannabinoids to shape the subjective experience (the entourage effect), the final feel will depend on Chimera’s terpene mix; without specific terpene data we recommend treating it as a notably potent hybrid.

Chimera is classified as a hybrid, which generally implies a blend of cerebral and bodily effects rather than a one-dimensional uplift or sedation. Hybrids can swing toward more energizing or more calming outcomes depending on phenotype and dose; given Chimera’s above-average THC, expect an experience that leans into the potency common to modern hybrids.

Chimera is best suited to consumers who want a pronounced hybrid effect and who are comfortable with stronger THC levels - mid-to-late day use often fits hybrids of this potency. Novices should start with a small amount and wait to assess impact before consuming more. For seasoned users, Chimera can be a good choice when you want something more potent than the average 20% strain but still balanced; for occasions that need a reliably noticeable effect, try it in controlled settings where you can gauge dose and timing.